• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

453.36 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,059
Open 453.36
Bid (Size) 451.00 (80)
Ask (Size) 456.20 (80)
Prev. Close 453.36
Today's Range 453.36 - 453.36
52wk Range 362.50 - 519.68
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Emerges as a Compelling Value Stock Candidate ↗
January 01, 2026
Via Chartmill
News headline image
The Best Stocks to Invest $1,000 in to Start the New Year Off Right ↗
January 01, 2026
These three stocks could make 2026 a happy new year for investors. 
Via The Motley Fool
Topics Artificial Intelligence

Performance

YTD
N/A
N/A
1 Month
+4.7%
+4.7%
3 Month
+10.9%
+10.9%
6 Month
-1.4%
-1.4%
1 Year
+11.7%
+11.7%

More News

Read More
News headline image
Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
December 31, 2025
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
Stay informed with the top movers within the S&P500 index on Tuesday. ↗
December 30, 2025
Via Chartmill
News headline image
Discover which S&P500 stocks are making waves on Tuesday. ↗
December 30, 2025
Via Chartmill
News headline image
2 Growth Stocks to Buy For 2026 and Beyond ↗
December 30, 2025
Via The Motley Fool
Topics Economy
News headline image
2 Nasdaq 100 Stocks Worth Investigating and 1 We Turn Down
December 28, 2025
Via StockStory
Topics Electric Vehicles World Trade
News headline image
3 Supercharged Growth Stocks to Buy and Hold Into the 2030s ↗
December 28, 2025
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Forget Moderna Stock, This is a Much Better Buy ↗
December 27, 2025
Via The Motley Fool
Topics Intellectual Property
News headline image
The $1.7 Billion Pivot: Agios Pharmaceuticals (AGIO) and the New Frontier of Oral Thalassemia Therapy
December 24, 2025
Via PredictStreet
Topics Economy
News headline image
Is CRISPR Therapeutics Stock Yesterday's News? ↗
December 24, 2025
Via The Motley Fool
News headline image
Vertex to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12
December 22, 2025
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
Moderna (MRNA): The “Act 2” of an mRNA Pioneer – A 2025 Deep Dive
December 22, 2025
Via PredictStreet
Topics Earnings Initial Public Offering Intellectual Property
News headline image
Vertex Pharmaceuticals Inc (NASDAQ:VRTX): A GARP Case Study in Affordable Growth ↗
December 22, 2025
Via Chartmill
News headline image
2 Cash-Producing Stocks to Consider Right Now and 1 We Find Risky
December 21, 2025
Via StockStory
News headline image
Is CRISPR Therapeutics a Buy, Sell, or Hold in 2026? ↗
December 19, 2025
Via The Motley Fool
News headline image
2 Reasons to Watch VRTX and 1 to Stay Cautious
December 17, 2025
Via StockStory
Topics Stocks
News headline image
From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes
December 16, 2025
From USA News Group
Via GlobeNewswire
News headline image
12 Days of Investing: My Top 12 Stocks to Buy Before 2026 ↗
December 15, 2025
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Vertex Pharmaceuticals (NASDAQ:VRTX) Combines Strong Growth with Technical Breakout Potential ↗
December 15, 2025
Via Chartmill
News headline image
2 Healthcare Stocks to Buy Ahead of the New Year ↗
December 12, 2025
Via The Motley Fool
News headline image
Beyond AI: How Non-AI Tech Innovations are Fueling a New Era of Stock Market Growth
December 11, 2025
Via MarketMinute
Topics Artificial Intelligence Economy Emissions
News headline image
1 Large-Cap Stock to Consider Right Now and 2 Facing Challenges
December 08, 2025
Via StockStory
News headline image
Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals? ↗
December 06, 2025
Via The Motley Fool
News headline image
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions
December 06, 2025
From Vertex Pharmaceuticals Incorporated
Via Business Wire

Frequently Asked Questions

Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 453.36
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 12/31/25 04:00 PM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 117.61B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 118B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap